Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer

Journal of Steroid Biochemistry and Molecular Biology

Volumn 89-90, Issue , 2004, Pages 533-537

  Jacobs, Elizabeth T ^a,b   Giuliano, Anna R ^a,b   Martínez, María Elena ^a,b   Hollis, Bruce W ^c   Reid, Mary E ^d   Marshall, James R ^d  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

1,25 Dihydroxyvitamin D; 25 Hydroxyvitamin D; Prostate cancer

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; VITAMIN D RECEPTOR;

CANCER RISK; CELL PROLIFERATION; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; ENZYME ACTIVITY; EVALUATION; GENETIC TRANSCRIPTION; HUMAN; MATHEMATICAL COMPUTING; PROSTATE CARCINOMA;

AGED; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RISK FACTORS; VITAMIN D;

EID: 3042592220     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2004.03.063     Document Type: Conference Paper

References (29)

1. Jemal A., Murray T., Samuels A., Ghafoor A., Ward E., Thun M.J. Cancer statistics. CA Cancer J. Clin. 53:2003;5-26
2. Pienta K.J., Goodson J.A., Esper P.S. Epidemiology of prostate cancer: molecular and environmental clues. Urology. 48:1996;676-683
3. Haenszel W., Kurihara M. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J. Natl. Cancer Inst. 40:1968;43-68
4. Chan J.M., Giovannucci E.L. Dairy products, calcium, and Vitamin D and risk of prostate cancer. Epidemiol. Rev. 23:2001;87-92
5. Berndt S.I., Carter H.B., Landis P.K., Tucker K.L., Hsieh L.J., Metter E.J., Platz E.A. Calcium intake and prostate cancer risk in a long-term aging study: the Baltimore Longitudinal Study of Aging. Urology. 60:2002;1118-1123
6. Giovannucci E., Clinton S.K. Tomatoes, lycopene, and prostate cancer. Proc. Soc. Exp. Biol. Med. 218:1998;129-139
7. Duffield-Lillico A.J., Reid M.E., Turnbull B.W., Combs G.F., Slate E.H., Fischbach L.A., Marshall J.R., Clark L.C. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol. Biomarkers Prev. 11:2002;630-639
8. Giovannucci E., Rimm E.B., Colditz G.A., Stampfer M.J., Ascherio A., Chute C.C., Willett W.C. A prospective study of dietary fat and risk of prostate cancer. J. Natl. Cancer Inst. 85:1993;1571-1579
9. Schwartz G.G., Hulka B.S. Is Vitamin D deficiency a risk factor for prostate cancer? Anticancer Res. 10:1990;1307-1311
10. M.F. Holick, Evolution, biologic functions, and recommended dietary allowances for Vitamin D, in: M.F. Holick (Ed.), Vitamin D: Physiology, Molecular Biology, and Clinical Applications, Humana Press, Totowa, NJ, 1999, pp. 1-16.
11. M.F. Holick, Vitamin D, in: M.E. Shils, J.A. Olson, M. Shike, A.C. Ross (Eds.), Modern Nutrition in Health and Disease, Williams & Wilkins, Baltimore, MD, 1999, pp. 329-345.
12. Haussler M.R., Whitfield G.K., Haussler C.A., Hsieh J.C., Thompson P.D., Selznick S.H., Dominguez C.E., Jurutka P.W. The nuclear Vitamin D receptor: biological and molecular regulatory properties revealed. J. Bone Miner. Res. 13:1998;325-349
13. Krill D., DeFlavia P., Dhir R., Luo J., Becich M.J., Lehman E., Getzenberg R.H. Expression patterns of Vitamin D receptor in human prostate. J. Cell. Biochem. 82:2001;566-572
14. 3 on primary cultures of human prostatic cells. Cancer Res. 54:1994;805-810
15. 3 decreases human prostate cancer cell adhesion and migration. Mol. Cell. Endocrinol. 164:2000;133-143
16. Getzenberg R.H., Light B.W., Lapco P.E., Konety B.R., Nangia A.K., Acierno J.S., Dhir R., Shurin Z., Day R.S., Trump D.L., Johnson C.S. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system. Urology. 50:1997;999-1006
17. 3. Cancer Epidemiol. Biomarkers Prev. 7:1998;391-395
18. Corder E.H., Guess H.A., Hulka B.S., Friedman G.D., Sadler M., Vollmer R.T., Lobaugh B., Drezner M.K., Vogelman J.H., Orentreich N. Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol. Biomarkers Prev. 2:1993;467-472
19. Ahonen M.H., Tenkanen L., Teppo L., Hakama M., Tuohimaa P. Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control. 11:2000;847-852
20. Nomura A.M., Stemmermann G.N., Lee J., Kolonel L.N., Chen T.C., Turner A., Holick M.F. Serum Vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States). Cancer Causes Control. 9:1998;425-432
21. Gann P.H., Ma J., Hennekens C.H., Hollis B.W., Haddad J.G., Stampfer M.J. Circulating Vitamin D metabolites in relation to subsequent development of prostate cancer. Cancer Epidemiol. Biomarkers Prev. 5:1996;121-126
22. Braun M.M., Helzlsouer K.J., Hollis B.W., Comstock G.W. Prostate cancer and prediagnostic levels of serum Vitamin D metabolites (Maryland, United States). Cancer Causes Control. 6:1995;235-239
23. Clark L.C., Combs G.F., Turnbull B.W., Slate E.H., Chalker D.K., Chow J., Davis L.S., Glover R.A., Graham G.F., Gross E.G., Krongrad A., Lesher J.L., Park H.K., Sanders B.B., Smith C.L., Taylor J.R. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: A randomized controlled trial. J. Am. Med. Assoc. 276:1996;1957-1963
24. Hollis B.W. Assay of circulating 1, 25-dihydroxyvitamin D involving a novel single-cartridge extraction and purification procedure. Clin. Chem. 32:1986;2060-2063
25. 125I -labeled tracer Clin. Chem. 42:1996;586-592
26. 125I -labeled tracer Clin. Chem. 39:1993;529-533
27. Malabanan A., Veronikis I.E., Holick M.F. Redefining Vitamin D insufficiency. Lancet. 351:1998;805-806
28. Xu Y., Shibata A., McNeal J.E., Stamey T.A., Feldman D., Peehl D.M. Vitamin D receptor start codon polymorphism (FokI) and prostate cancer progression. Cancer Epidemiol. Biomarkers Prev. 12:2003;23-27
29. Ingles S.A., Ross R.K., Yu M.C., Irvine R.A., La Pera G., Haile R.W., Coetzee G.A. Association of prostate cancer risk with genetic polymorphisms in Vitamin D receptor and androgen receptor. J. Natl. Cancer Inst. 89:1997;166-170